Alhavi Pharmaceutical Company
Alhavi Pharmaceutical Company
Alhavi Pharmaceutical Company is a Tehran-based pharmaceutical manufacturer with roots in the former Parke-Davis facility on the Tehran-Karaj corridor. In the Hormuz Group company graph, it matters because it connects local medicine manufacturing, pediatric products, oral dosage forms, healthcare distribution, and pharmaceutical quality systems. Its role is most relevant to domestic drug availability and import substitution rather than direct capital-market exposure.
Products & Services
Alhavi Pharmaceutical Company manufactures pharmaceutical products in dosage forms including tablets, capsules, syrups, elixirs, suspensions, drops, and pediatric medicines. Its operations are linked to domestic drug supply, pharmacy distribution, child-health products, common therapeutic categories, imported pharmaceutical inputs, quality systems, and regulated healthcare manufacturing.
Investment Relevance
Alhavi is relevant for investors assessing Iran's private pharmaceutical manufacturing base, domestic drug supply resilience, pediatric medicine demand, quality-system maturity, and dependence on imported active ingredients and excipients. It can support analysis of medicine shortages, pharmacy-channel supply, contract manufacturing potential, and regulated healthcare demand. Due diligence should verify ownership, current licenses, GMP status, product registrations, raw-material sourcing, distributor relationships, factory utilization, export activity, and exposure to pricing regulation.
Connected Intelligence
This profile is connected to Hormuz taxonomy layers across geography, industry, market exposure, and investment constraints.
Source & Verification Note
Based on public company, official-company, pharmaceutical-sector, healthcare, and market-related information. Further verification is required before treating this profile as verified investment intelligence.